Literature DB >> 16190956

Possible pathologenic role of interleukin-5 and eosino cationic protein in Henoch-Schönlein purpura nephritis.

Yukihiko Kawasaki1, Mitsuaki Hosoya, Hitoshi Suzuki.   

Abstract

BACKGROUND: The mechanism for the onset of Henoch-Schönlein purpura nephritis is unknown. In order to identify the pathogenesis of nephritis, laboratory findings and serum cytokines between Henoch-Schönlein purpura (HSP) patients without nephritis and with nephritis were investigated.
METHODS: We enrolled 32 patients who had been diagnosed with HSP from January 1993 to December 1998. These patients were divided into two groups. Group 1 consisted 12 patients without nephritis and group 2 consisted 20 patients with nephritis. We evaluated laboratory findings such as eosinophil counts, serum IgE, eosino cationic protein (ECP), and serum cytokine (interleukin (IL)-2, IL-4, IL-5, IL-6, IL-10, IL-13 interferon-gamma and tumor necrotic factor-alpha) concentrations between both groups.
RESULTS: At the acute phase, serum IL-5 and ECP concentrations in group 2 were higher than those in group 1 (59.4 +/- 32.7 pg/mL vs. 10.8 +/- 12.8 pg/mL, P < 0.05, 24.3 +/- 5.1 microg/L vs. 8.9 +/- 4.2 microg/L, P < 0.05, respectively). Serum IL-4 concentrations at the acute phase in group 1 were higher than those in group 2 (40.2 +/- 21.5 pg/mL vs. 10.7 +/- 5.4 pg/mL, P < 0.01). In group 2, serum IL-5 concentrations at the acute phase were higher than those at recovery phase.
CONCLUSIONS: These findings suggest that IL-5 and eosinophil activation may be one of the factors involved in the mechanism for onset of nephritis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16190956     DOI: 10.1111/j.1442-200x.2005.02115.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  14 in total

1.  Eosinophil cationic protein in Henoch-Schönlein purpura.

Authors:  Castellazzi Massimo Luca; Emanuela Anna Laicini; Emilio F Fossali
Journal:  World J Pediatr       Date:  2014-02       Impact factor: 2.764

Review 2.  [Research advances in immunological pathogenesis of immunoglobulin A vasculitis].

Authors:  Ya-Ting Liu; Si-Guang Lu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-07

3.  Investigation of the change in CD4⁺ T cell subset in children with Henoch-Schonlein purpura.

Authors:  Yuan-Yuan Li; Cheng-Rong Li; Guo-Bing Wang; Jun Yang; Ying Zu
Journal:  Rheumatol Int       Date:  2011-12-21       Impact factor: 2.631

4.  Association between allergic diseases and risks of HSP and HSP nephritis: a population-based study.

Authors:  An-Chyi Chen; Cheng-Li Lin; Te-Chun Shen; Tsai-Chung Li; Fung-Chang Sung; Chang-Ching Wei
Journal:  Pediatr Res       Date:  2015-12-21       Impact factor: 3.756

Review 5.  Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management.

Authors:  Jun-Yi Chen; Jian-Hua Mao
Journal:  World J Pediatr       Date:  2014-12-29       Impact factor: 2.764

Review 6.  The pathogenesis and treatment of pediatric Henoch-Schönlein purpura nephritis.

Authors:  Yukihiko Kawasaki
Journal:  Clin Exp Nephrol       Date:  2011-06-23       Impact factor: 2.801

7.  A case of Crohn's disease associated with Takayasu's arteritis and Henoch-Schönlein purpura.

Authors:  Kotaro Ogawa; Takayuki Matsumoto; Shinichiro Yada; Atsushi Hirano; Yoshiteru Kumagae; Kenichi Goto; Kazunori Urabe; Mitsuo Iida
Journal:  Clin J Gastroenterol       Date:  2009-02-17

Review 8.  Henoch-Schönlein purpura nephritis in children.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Nat Rev Nephrol       Date:  2014-07-29       Impact factor: 28.314

9.  The role of chemokines in Henoch Schonlein Purpura.

Authors:  Fulya Tahan; Ismail Dursun; Hakan Poyrazoglu; Metin Gurgoze; Ruhan Dusunsel
Journal:  Rheumatol Int       Date:  2007-03-27       Impact factor: 3.580

Review 10.  Pathogenesis of Henoch-Schönlein purpura nephritis.

Authors:  Keith K Lau; Hitoshi Suzuki; Jan Novak; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2009-06-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.